Evidence-based care guideline for pediatric constraint induced movement therapy (CIMT).

GUIDELINE TITLE
Evidence-based care guideline for pediatric constraint induced movement therapy (CIMT).

BIBLIOGRAPHIC SOURCE(S)
Cincinnati Children's Hospital Medical Center. Evidence-based care guideline for pediatric constraint induced movement therapy (CIMT). Cincinnati (OH): Cincinnati Children's Hospital Medical Center; 2009 Feb 16. 17 p. [45 references]

GUIDELINE STATUS
This is the current release of the guideline.

** REGULATORY ALERT **
FDA WARNING/REGULATORY ALERT
Note from the National Guideline Clearinghouse: This guideline references a drug(s) for which important revised regulatory and/or warning information has been released.

August 3, 2009 - Onabotulinum toxin A (Botox/Botox Cosmetic), Abobotulinum toxin A (Dysport) and Rimabotulinum toxin B (Myobloc): The U.S. Food and Drug Administration (FDA) notified healthcare professionals of changes to the established drug names for Botox/Botox Cosmetic, Dysport and Myobloc to reinforce individual potencies and prevent medication errors, and provided recommendations for healthcare professionals to consider, plus information for patients, family members, and caregivers.

abrir aquí para acceder al documento NGC AHRQ completo:
http://www.guideline.gov/summary/summary.aspx?ss=15&doc_id=14286&nbr=&string=